Conduit Pharmaceuticals Ownership | Who Owns Conduit Pharmaceuticals?


OverviewRevenueFinancialsChart

Conduit Pharmaceuticals Ownership Summary


Conduit Pharmaceuticals is owned by 21.99% insiders, and 78.00% retail investors.

CDT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockConduit Pharmaceuticals-21.99%78.00%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-97.22%20,000-99.76%-7.69%1-96.55%--100.00%
Dec 31, 20243818.75%8,729,799115.70%-2486.44%3020.00%2-50.00%
Sep 30, 20243210.34%4,047,17538.34%-1480.05%25-433.33%
Jun 30, 20242961.11%2,925,51981.56%-4153.32%2578.57%350.00%
Mar 31, 20241863.64%1,611,34317.18%-2586.37%1427.27%2-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 03, 2024Nirland Ltd-Sell$156.45K
Oct 07, 2024Nirland Ltd-Sell$96.53K
Oct 04, 2024Nirland Ltd-Sell$140.46K
Oct 01, 2024Nirland Ltd-Sell$141.38K
Sep 30, 2024Nirland Ltd-Sell$122.02K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4-5
2024 Q3-11
2024 Q211

CDT Ownership FAQ


Who Owns Conduit Pharmaceuticals?

Conduit Pharmaceuticals shareholders are primarily institutional investors at 0.00%, followed by 21.99% insiders and 78.01% retail investors. The average institutional ownership in Conduit Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Conduit Pharmaceuticals falls below.

Does Blackrock own Conduit Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Conduit Pharmaceuticals.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools